Conference News
Conference News
- 'Doesn't Fit Anything I Trained for': Treating Chronic Lyme
- AIDS 2024 Twice-Yearly PrEP Gives 'Huge' 100% Protection
- EULAR 2024 Taper, Dose Down, Discontinue: Striving for Less Steroid Use
- GRAPPA 2024 MACE Risk Similar Among Biologics for Psoriasis, PsA
- GRAPPA 2024 Adverse Events Differ Between Two Second-Line Psoriasis Rxs
- GRAPPA 2024 MHC-1-Opathies Linked to Ancient Retrovirus Infections
- ASRS 2024 More Anti-VEGF Injections Might Increase Visual Acuity
- ASRS 2024 Are GLP-1s Bad for Retinas?
- GRAPPA 2024 Psoriatic Arthritis Treatment Failure Tied to Key Factors
- SPD 2024 Pediatric Rheumatology/Dermatology Clinic: Benefits Explored
- ASRS 2024 Novel Gene Therapy Safe for Retinitis Pigmentosa
- AIDS 2024 Remembering HIV Leaders Shot Down in Plane
- SPD 2024 Underserved Families Sound Off on Pediatric Derm Access
- ASRS 2024 Here's How to Have 'Greener' Intravitreal Injections
- SPD 2024 Munchausen Syndrome by Proxy: Be Aware of Cutaneous Signs
- SPD 2024 Colchicine Effective for Pediatric Aphthous Ulcers
- ASRS 2024 Retinal Detachment Still Sticky Issue for Stickler Syndrome
- GRAPPA 2024 MSK Symptoms, Psoriasis: Dermatologists or Rheumatologists?
- ASRS 2024 Eyes With IOLs Do Worse With In-Office Retina Repair
- SPD 2024 Consider Risks for Some Topical Ingredients in Children